GeromedicinePhysiologyPeer-reviewed journal article
The senescence-inhibitory p53 isoform Δ133p53α represses the proinflammatory chemokine CXCL10 in progeria model mice and naturally aged mice
Leo YamadaiD, Huaitian LiuiD, Curtis C. HarrisiD, Izumi HorikawaiD
Abstract
Aims{Delta}133p53 is a naturally occurring isoform of the human p53 protein that inhibits p53-mediated cellular senescence. We previously reported that transgenic expression of this senescence-inhibitory p53 isoform counteracts aging-associated pathological changes in progeria model mice (heterozygous LmnaG609G/+). The anti-aging effect of {Delta}133p53 was attributed in part to reduced levels of the proinflammatory cytokine IL-6. This study aims to comprehensively profile {Delta}133p53-induced changes in cytokines and chemokines. MethodsA Luminex-based multiplex quantitative assay was performed using mouse serum samples from transgenic {Delta}133p53-expressing LmnaG609G/+ mice and non-expressing controls. Quantitative RT-PCR and RNA in situ hybridization assays were used to assess Cxcl10 expression in mouse tissues. In addition, gene expression datasets from human tissues were analyzed. ResultsWe confirmed {Delta}133p53-mediated repression of serum IL-6 levels. We also found that {Delta}133p53 reduced serum levels of CXCL1, IL-1, and CXCL10. We further characterized CXCL10, which has not previously been associated with progeria in mice or humans. Consistent with reduced serum CXCL10 levels, both young (15-week-old) and old (10-month-old) {Delta}133p53-expressing LmnaG609G/+ mice showed reduced Cxcl10 expression in the liver, spleen, and brain, major organs that produce CXCL10, compared with age-matched non-expressing controls. In naturally aged wild-type mice (2 years old), transgenic {Delta}133p53 expression also significantly repressed Cxcl10 expression in the spleen and brain. An inverse association between CXCL10 and {Delta}133p53 levels was observed in human spleen tissues, suggesting physiological relevance to human aging. ConclusionCXCL10, a proinflammatory chemokine elevated in both accelerated and natural aging, is a potential target of the anti-inflammatory activity of {Delta}133p53.
- organism: mouse
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 20th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Senescence-inhibitory Δ133p53α counteracts accelerated ageing and mortality
Leo Yamada, Huaitian Liu, … Izumi Horikawa·bioRxiv·Feb 7, 2026
- Pharmacologic activation of Δ133p53α reduces cellular senescence in progeria patients-derived cells
Sebastien M. Joruiz, Delphine Lissa, … Curtis C. Harris·bioRxiv·Jul 28, 2025
- CXCL10/CXCR3 Signaling Induces Neural Senescence and Cognitive Impairments
Monika Patel, Sakesh Kumar, … Prem Narayan Yadav·bioRxiv·Oct 16, 2024
- ASK1 promotes inflammation in senescence and aging
T. Odawara, S. Yamauchi, H. Ichijo·bioRxiv·Sep 20, 2023
- Linked regulation of genome integrity and senescence-associated inflammation by p53
K. N. Miller, B. Li, … P. D. Adams·bioRxiv·Nov 20, 2023
- MLKL deficiency protects against low-grade, sterile inflammation in aged mice
E. C. Tovey, S. E. Garnish, … J. M. Hildebrand·bioRxiv·Oct 17, 2022